We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

45 hedge funds and large institutions have $120M invested in Tempest Therapeutics in 2014 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 3

300% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 3

62% more capital invested

Capital invested by funds: $73.9M → $120M (+$45.7M)

25% more funds holding

Funds holding: 36 → 45 (+9)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
45
Holders Change
+9
Holders Change %
+25%
% of All Funds
1.3%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
12
Increased
22
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$12.7M
2
DM
Deerfield Management
New York
+$10.3M
3
Jennison Associates
Jennison Associates
New York
+$6.89M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$4.85M
5
KCM
Kennedy Capital Management
Missouri
+$3.83M

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$2.06M
2
BCM
BBT Capital Management
Texas
-$794K
3
LOM
Loeb Offshore Management
New York
-$161K
4
FTUS
Flow Traders U.S.
New York
-$150K
5
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$28.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$325K – – –
Morgan Stanley
27
Morgan Stanley
New York
$314K +$255K +9 +300%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$280K +$56.7K +2 +22%
BIM
29
BlackRock Investment Management
Delaware
$278K +$85K +3 +38%
Citigroup
30
Citigroup
New York
$259K +$255K +9 +900%
BCM
31
Bridgeway Capital Management
Texas
$226K – – –
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$193K +$56.7K +2 +40%
SIM
33
Spark Investment Management
New York
$180K +$198K +7 New
BA
34
BlackRock Advisors
Delaware
$165K +$28.3K +1 +20%
PAM
35
Panagora Asset Management
Massachusetts
$161K -$28.3K -1 -14%
Charles Schwab
36
Charles Schwab
California
$115K – – –
CS
37
Credit Suisse
Switzerland
$106K +$113K +4 New
TA
38
Teachers Advisors
New York
$103K – – –
NFA
39
Nationwide Fund Advisors
Ohio
$71K +$28.3K +1 +50%
AIG
40
American International Group
New York
$54.5K – – –
Deutsche Bank
41
Deutsche Bank
Germany
$41K +$28.3K +1 +100%
U
42
UBS
Switzerland
$35K – – –
BRWM
43
B. Riley Wealth Management
Tennessee
$17K +$28.3K +1 New
TRCT
44
Tower Research Capital (TRC)
New York
$14K +$28.3K +1 New
WEC
45
Winslow Evans & Crocker
Massachusetts
$8.94K – – –
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
$3.21K – – –
Barclays
47
Barclays
United Kingdom
$3K – – –
AllianceBernstein
48
AllianceBernstein
Tennessee
$2K – – –
Bank of America
49
Bank of America
North Carolina
$1K – – –
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$28 -$28.3K -1 -50%
1
2
3

TPST Hedge Fund Activity: Q1 2014 in Review

45 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2014, worth a combined $120M — up 62% from $73.9M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new TPST positions and 3 closed out — a net gain of 9 holders — while 22 added to existing stakes and 3 trimmed.

The largest buyer was Adage Capital Partners, opening a new position worth an estimated $12.7M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $2.06M sold.

  • 45 institutional investors held Tempest Therapeutics (TPST) as of Q1 2014, up from 36 in Q4 2013.
  • Funds reported $120M of Tempest Therapeutics stock for Q1 2014, up 62% quarter-over-quarter.
  • 12 funds opened new Tempest Therapeutics positions in Q1 2014 and 3 closed out, a net change of +9 holders.
  • The largest Tempest Therapeutics buyer in Q1 2014 was Adage Capital Partners, an estimated $12.7M added.
  • The largest Tempest Therapeutics seller in Q1 2014 was JP Morgan Chase, an estimated $2.06M sold.

Based on aggregated 13F filings for Q1 2014.